The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Allied Healthcare Products Inc. To summarize, we found that Allied Healthcare Products Inc ranked in the 7th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 94%. The most interesting components of our discounted cash flow analysis for Allied Healthcare Products Inc ended up being:
As a business, AHPI is generating more cash flow than merely 3.47% of positive cash flow stocks in the Healthcare.
The business' balance sheet reveals debt to be 1% of the company's capital (with equity being the remaining amount). Approximately only 6.03% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
Allied Healthcare Products Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Allied Healthcare Products Inc? See OFIX, SRDX, GRFS, MYGN, and CRY.